Intestinal Antigenicity of Ovarian Mucinous Cystadenomas by Nairn, R. C. et al.
276
INTESTINAL ANTIGENICITY OF OVARIAN MUCINOUS
CYSTADENOMAS
R. C. NAIRN, A. C. WALLACE* AND E. P. G. GULI
From the Department ofPathology, Monctsh University, Melbourne, Australia
Received for publication March 9, 1971
SUMMARY.-Immunofluorescent tracing by rabbit antiserum with specific
reactivity against intestinal mucosa revealed cross-reaction with human
ovarian mucinous cystadenoma epithelium and not with epithelium of any of
several otherhuman mucous epithelia. The mucinous cystadenomaepithelium
apparently contains at least one but not all of the specific intestinal mucosal
antigens. The findings support theviewthat such tumours are histogenetically
of intestinal type, as might occur for example by unilateral intestinal develop-
ment of a teratoma.
THE availability of a specific antiserum to an intestinal mucin prompted us
to study its reactivity against the epithelium of mucinous ovarian cystadenomas.
There are varying views (summarized by Evans, 1966) on the histogenesis of
these ovarian tumours that, for example, they arise from Brenner tumours,
follicular cells, metaplastic mesothelium, or by unilateral endodermal (intestinal)
development from a multipotential cell. The last hypothesis would make the
lesions analogous to, say, the dermoid cyst or struma ovarii with their unilateral
ectodermal orthyroidglandular developmentrespectively. Thepossibleintestinal
nature of the epithelium has some support in the reported identification of intes-
tinal enzymes in the mucinous cyst fluid (Tachibana, 1929; Cariker and Dockerty,
1954). The present study in demonstrating by immunofluorescence specific
intestinal antigenicity in the epithelium and mucin ofthe tumour provides strong
further evidence in favour of its intrinsic intestinal histogenesis.
METHODS
The intestinal-specific antisera were prepared by immunizing rabbits with a
microsome fraction ofhuman colon mucosa obtained from fresh surgical specimens
(Nairn et al., 1962a). Its intestinalspecificitywasestablishedbyserialabsorptions
with group AB human red cells and with homogenates of human kidney, lung,
and bronchus. These absorptions were designed to remove respectively any
antibodies against bloodgroup substances, human species and other tissue antigens
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EXPLANATION OF PLATE
FIG. 1.-Frozen section human ovarian mucinous cystadenoma treated with rabbit anti-
intestinal serum absorbed withhumanAB red cells, kidney, lung andbronchushomogenates;
sandwich immunofluorescent staining with fluorescein-labelled goat anti-rabbit-globulin.
Bright staining of epithelium. x 250.
FIG. 2.-Immunofluorescent staining ofnormal human colon mucosa treated as for Fig. 1. x 250.BRITISH JOURNAL OF CANCER.
A%. 40
2
Nairn, Wallace and Guli
VOl. XXV, NO. 2.OVARIAN MUCINOUS CYSTADENOMAS
and non-intestinal mucins. Removal ofprecipitating antibodies to non-intestinal-
specific antigens by these absorptions was confirmed by double immunodiffusion
tests in agar gels on microscope slides. Further absorptions were conducted with
homogenate of mucinous cystadenomas and freeze-dried mucin from one cysta-
denoma, or with colon homogenate.
Sandwich immunofluorescent staining (Nairn, 1969) was carried out on cryostat
frozen sections of various glandular tissue blocks snap-frozen in a liquid nitrogen-
isopentane slurry. The tissues studied included colon, colon cancer, bronchus,
salivary gland, pancreas, bile duct, prostate, cervix and nine ovarian cystic
tumours (three mucinous and two serous cystadenomas; two mucinous and two
serous cystadenocarcinomas). Most of the tissue blocks were from fresh surgical
operation specimens, but a few were from autopsy material taken about 8 hours
after death; this had been shown not to be materially different in relevant anti-
genicity from the operation specimens.
Sections, after fixation in ethanol at 0c C. for 3 minutes and air drying, were
treated either with preimmune or immune sera after the various absorptions and
at a dilution of 1 in 5, for 30 minutes at room temperature in a damp atmosphere.
They were rinsed and washed in two changes of buffered saline (0.145 M NaCl,
0*01 M phosphate, pH 7.1) and any bound antibody traced with fluorescein isothio-
cyanate-conjugated goat anti-rabbit-globulin. This had a fluorescein to protein
molar ratio of 3-6 and predominant reactivity against IgG; before use it was
absorbed several times with human tissue homogenates and diluted 1 in 4 so that
by itself it gave no staining whatever of the various glandular tissues. It was
applied for 30 minutes to the sections, which were then rinsed and washed with
buffered saline as before. After mounting in buffered glycerol, the stained sections
were examined by darkground ultraviolet fluorescence microscopy with a colour-
less barrier filter.
Specificity ofany immunofluorescent staining was established by its limitation
to mucous epithelia, and its absence with normal pre-immune rabbit serum or
with the appropriately absorbed immune serum. The presence of any acid muco-
polysaccharide-secreting epithelium in the various tissues was established in all
cases by staining parallel sections with alcian blue at pH 2-8.
RESULTS
The findings are summarized in Table I, which shows that the antiserum
absorbed with only the red cells and human kidney and lung stained all the
mucous epithelia, indicating some common antigenicity; reaction was strongest
with colon and ovarian mucinous cystadenoma. After the absorption with bron-
chus, only the epithelium of the mucinous cystadenomas and ofthe normal colon
could be stained (Fig. 1 and 2). There was no intestinal-specific staining of the
serous cystadenomas or of any ofthe cystadenocarcinomas.
Absorption of the antiserum by the mucinous cystadenoma wall homogenate
combined with freeze-dried mucin completely inhibited staining ofthe cystadeno-
mas and substantially reduced that of colon. All specific reactivity of the serum
was abolished by the colon homogenate absorptions. It was important not to
misinterpret asspecific staining inconstant reactivitywith concentrated inspissated
mucus found in occasional histological preparations (e.g. salivary gland); this was
obtained equally with pre-immune and immune sera and could not be completely
inhibited by the absorptions.
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TABLE I.-Immunofluorescent Staining of Mucous Glandular Epithelia by
Anti-intestine Serum after Absorption by Human Tissues
Antiserum absorbed by Preimmune
serum
AB red cells, kidney and lung absorbed by
homogenates kidney and
colon lung
+ cysta- homo- homogenate
+ bronchus denoma genate
Colon . +++ ++ + - -
Colon carcinoma
Bronchus
Salivary gland +. . . ++
Pancreas F
Bile duct J
Prostate + Cervix f + - +
Ovarian mucinous cystadenoma +++ ± + +
Ovarian serous cystadenoma . +
Ovarian mucinous cystadenocarci-
noma ± - . +
Ovarian serous cystadenocarcinoma .
DISCUSSION
The organ-specificity of this antiserum has been established previously, and
when appropriately absorbed, its staining reactivity is limited to mammalian
intestinal mucin without cross-reaction with other normal tissues (Nairn et al.,
1962a; de Boer et al., 1969). In this study we have demonstrated cross-reactivity
with the epithelium of three benign mucinous cystadenomas indicating intestinal
antigenicity here. The fact that reactivity with colonic mucosa could be only
partly suppressed by absorption ofthe antiserum with cystadenoma suggests that
at least two antibodies may be concerned in the colon staining. One antibody
apparently cross-reacts with colon and cystadenoma, and the other is against an
exclusively intestinal antigen.
The immunofluorescence and absorption studies confirm the well known fact
that mucinous cystadenomas contain some mucins which have a general distribu-
tion in the mucous epithelia ofthe body, and also reveal that there is at least one
mucin undetected in all the other tissues examined except colon mucosa. It
might be speculated that the antigen found only in colon is a reflection ofintestinal
maturation which has no counterpart in the ovarian tumours. A large series of
cystic ovarian tumours should be investigated in this wayto decide ifthis antigenic
pattern is a general phenomenon.
The finding of McNeil et al. (1969) of colon cancer specificity exhibited by an
antiserum to ovarian mucinous cyst fluid has not been investigated in this study
though we have reconfirmed the lack of intestinal specificity in adenocarcinomas
ofthe colon (Nairn etal., 1962b). Thefailure todemonstrate intestinalantigenicity
in mucinous cystadenomas in the initial studies with this antiserum is perhaps
attributable to the relatively primitive immunofluorescence techniques employed
10 years ago. In particular the present procedure ofsnap-freezing oftissue blocks
in liquid nitrogen-isopentane for cryostat sectioning has vastly improved preser-
vation of tissue morphology and antigenicity. The absence of intestinal antigeni-
city in the mucinous cystadenocarcinomas is presumably yet another example of
loss of organ-specificity, which appears to be a general feature of malignancy
(Nairn et al., 1966).
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